Advanz Pharma Buys Tostran®, Kyowa Kirin’s Testosterone Gel

The UK- based multinational pharma corporation, Advanz Pharma, which works particularly in medication for hospital settings and specialty conditions, has partnered with Kyowa Kirin to purchase the testosterone replacement treatment, Tostran®.

Tostran® is a gel product developed for men with hypogonadism who show symptoms that indicate low levels of testosterone.

The deal is anticipated to be closed in the second quarter of this year.

The purchase will help support Advanz Pharma’s goal of expanding in Europe while enhancing its line of specialised medications.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.